The tumour-stromal interaction between intratumoral c-Met and stromal hepatocyte growth factor associated with tumour growth and prognosis in non-small-cell lung cancer patients

British Journal of Cancer

Volumn 90, Issue 8, 2004, Pages 1555-1562

  Masuya, D ^a   Huang, C ^a   Liu, D ^a   Nakashima, T ^a   Kameyama, K ^a   Haba, R ^a   Ueno, M ^a   Yokomise, H ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

c Met; HGF; Immunohistochemistry; Ki 67; Lung cancer

Indexed keywords

HEPATOCYTE GROWTH FACTOR C MET; KI 67 ANTIGEN; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CELL INTERACTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STROMA CELL; SURVIVAL RATE; TUMOR CELL; TUMOR GROWTH; TUMOR VASCULARIZATION; BIOSYNTHESIS; CELL COMMUNICATION; CELL DIVISION; DISEASE COURSE; GENE EXPRESSION REGULATION; LUNG TUMOR; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY; SURVIVAL;

CARCINOMA, NON-SMALL-CELL LUNG; CELL COMMUNICATION; CELL DIVISION; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATOCYTE GROWTH FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LUNG NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-MET; STROMAL CELLS; SURVIVAL ANALYSIS;

EID: 2442513981     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601718     Document Type: Article

References (35)

1. Bottaro DP, Rubin JS, Faletto DL, Chan AM-L, Kmiecik TE, Vande Wounde GF, Aaronson SA (1991) Identification of the hepatocyte growth factor receptor as the c-met prot-oncogene product. Science 251: 802-804
2. Brinkmann V, Foroutan H, Sachs M, Weidner KM, Birchmeier W (1995) Hepatocyte growth factor/scatter factor induces a variety of tissue-specific morphogenic programs in epithelial cells. J Cell Biol 131: 1573-1586
3. Bussolino F, Di Renzo MF, Ziche M, Bocchietto E, Olivero M, Naldini L, Gaudino G, Tamagnone L, Coffer A, Comoglio PM (1992) Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 119: 629-641
4. Chung LW (1995) The role of stromal-epithelial interaction in normal and malignant growth. Cancer Surv 23: 33-42
5. Cordon-Cardo C (1995) Mutation of cell cycle regulators: biological and clinical implications for human neoplasia. Am J Pathol 147: 545-560
6. Date K, Matsumoto K, Kuba K, Shimura H, Tanaka M, Nakamura T (1998) Inhibition of tumor growth and invasion by a four-kringle antagonist (HGF/NK4) for hepatocyte growth factor. Oncogene 17: 3045-3054
7. Edakuni G, Sasatomi E, Satoh T, Tokunaga O, Miyazaki K (2001) Expression of the hepatocyte growth factor/c-Met pathway is increased at the cancer front in breast carcinoma. Pathol Int 51: 172-178
8. Folkman J (1990) What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82: 4-6
9. Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1: 27-31
10. Gerde J, Lemke H, Baisch H, Wacker H, Schwab M, Stein H (1984) Cell cycle analysis of a cell-proliferation associated nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133: 1710-1715
11. Giordano S, Corso S, Conrotto P, Artigianni S, Gilestro G, Barberis D, Tamagnone L, Comoglio PM (2002) The semaphorin 4D receptor controls invasive growth by coupling with Met. Nat Cell Biol 4: 720-724
12. Ichimura E, Maeshima A, Nakajima T, Nakamura T (1996) Expression of c-met/HGF receptor in human non-small cell lung carcinomas in vitro and its prognostic significance. Jpn J Cancer Res 87: 1063-1069
13. Jin L, Fuchs A, Schnitt SJ, Yao Y, Joseph A, Lamszus K, Park M, Goldberg ID, Rosen EM (1997) Expression of scatter factor and c-met receptor in benign and malignant breast tissue. Cancer 79: 749-760
14. Kajita T, Ohta Y, Kimura K, Tamura M, Tanaka Y, Tsunezuka Y, Oda M, Sasaki T, Watanabe G (2001) The expression of vascular endothelial growth factor C and its receptors in non-small cell lung cancer. Br J Cancer 85: 255-260
15. Kuba K, Matsumoto K, Date K, Shimura H, Tanaka M, Nakamura T (2000) HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice. Cancer Res 60: 6737-6743
16. Kurimoto S, Moriyama N, Horie S, Sakai M, Kameyama S, Akimoto Y, Hirano H, Kawabe K (1998) Co-expression of hepatocyte growth factor and its receptor in human prostate cancer. Histochem J 30: 27-32
17. Masuya D, Huang C, Liu D, Kameyama K, Hayashi E, Yamauchi A, Kobayashi S, Haba R, Yokomise H (2001) The intratumoral expression of vascular endothelial growth factor and interleukin-8 associated with angiogenesis in nonsmall cell lung carcinoma patients. Cancer 92: 2628-2638
18. Matsuyama K, Chiba Y, Sasaki M, Tanaka H, Muraoka R, Tanigawa N (1998) Tumor angiogenesis as a prognostic marker in operable non-small cell lung cancer. Ann Thorac Surg 65: 1405-1409
19. Montesano R, Matsumoto K, Nakamura T, Orci L (1991) Identification of fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 61: 901-908
20. Mountain CF (1997) Revisions in the international system for staging lung cancer. Chest 111: 1710-1717
21. Nakamura T, Matsumoto K, Kiritoshi A, Tano Y, Nakamura T (1997) Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions. Cancer Res 57: 3305-3313
22. Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A, Tashiro K, Shimizu S (1989) Molecular cloning and expression of human hepatocyte growth factor. Nature 342: 440-443
23. Nakashima T, Huang C, Liu D, Kameyama K, Masuya D, Kobayashi S, Kinoshita M, Yokomise H (2003) Neural-cadherin expression associated with angiogenesis in non-small-cell lung cancer patients. Br J Cancer 88: 1727-1733
24. Olivero M, Rizzo M, Madeddu R, Casadio C, Pennacchietti S, Nicotra MR, Prat M, Maggi G, Arena N, Natali PG, Comoglio PM, Di Renzo MF (1996) Overexpression and activation of hepatocyte growth factor/scatter factor in human non-small-cell lung carcinomas. Br J Cancer 74: 1862-1868
25. Park M, Dean M, Kaul K, raun MJ, onda MA, Vande Wounde G (1987) Sequence of MET proto-oncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors. Proc Natl Acad Sci USA 84: 6379-6383
26. Ramirez R, Hsu D, Patel A, Fenton C, Dinauer C, Tuttle RM, Francis GL (2000) Over-expression of hepatocyte growth factor/scatter factor (HGF/ SF) and the HGF/SF receptor (cMET) are associated with a high risk of metastasis and recurrence for children and young adults with papillary thyroid carcinoma. Clin Endocrinol 53: 635-644
27. Scagliotti GV, Micela M, Gubetta L, Leonardo E, Cappia S, Borasio P, Pozz E (1993) Prognostic significance of Ki67 labelling in resected non small cell lung cancer. Eur J Cancer 29A: 363-365
28. Siegfried JM, Weissfeld LA, Singh-Kaw P, Weyant RJ, Testa JR, Landreneau RJ (1997) Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell cancer. Cancer Res 57: 433-439
29. Takanami I, Tanana F, Hashizume T, Kikuchi K, Yamamoto Y, Yamamoto T, Kodaira S (1996) Hepatocyte growth factor and c-Met/hepatocyte growth factor receptor in pulmonary adenocarcinomas: an evaluation of their expression as prognostic markers. Oncology 53: 392-397
30. Tamura M, Arakaki N, Tsubouchi H, Takeda H, Daikuhara Y (1993) Enhancement of human hepatocyte growth factor production by interleukin-1α and -β and tumor necrosis factor-α by fibroblast in culture. J Biol Chem 268: 8140-8145
31. Trusolino L, Bertotti A, Comoglio PM (2001) A signaling adapter function for α6β4 integrin in the control of HGF-dependent invasive growth. Cell 107: 643-654
32. Turkeri LN, Erton ML, Cevik I, Akdas A (1998) Impact of the expression of epidermal growth factor, transforming growth factor alpha, and epidermal growth factor receptor on the prognosis of superficial bladder cancer. Urology 51: 645-649
33. Webb CP, Taylor GA, Jeffers M, Fiscella M, Oskarsson M, Resau JH, Vande Wounde GF (1998) Evidence for a role of Met-HGF/SF during Ras-mediated tumorigenesis/metastasis. Oncogene 17: 2019-2025
34. Weidner KM, Arakaki N, Hartmann G, Vandekerckhove J, Weingart S, Rieder H, Fonatsch C, Tsubouchi H, Hishida T, Daikuhara Y, Birchmeier W (1991) Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc Natl Acad Sci USA 88: 7001-7005
35. Weidner KM, Behrens J, Vandekerckhove J, Birchmeier W (1990) Scatter factor: molecular characteristics and effect of the invasiveness of epithelial cells. J Cell Biol 111: 2097-2108